Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AI-MEL: Image Analysis and Machine Learning for Early Diagnosis and Risk Prediction in Children, Adolescents and Young Adults

NCT06621810 is registered in ClinicalTrials.gov with German Cancer Research Center as lead sponsor.

NCT NCT06621810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06621810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AI-MEL: Image Analysis and Machine Learning for Early Diagnosis and Risk Prediction in Children, Adolescents and Young Adults
Lead sponsor
German Cancer Research Center
Phase
Observational
Overall status
Recruiting
Start date
December 1, 2022
Completion date
November 30, 2026
Enrollment
3,000 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

artificial intelligence (ai), melanoma (skin cancer), pediatric cancer